Clinical validation of the cobas 4800 HPV test for cervical screening purposes
- PMID: 21880968
- PMCID: PMC3209101
- DOI: 10.1128/JCM.05552-11
Clinical validation of the cobas 4800 HPV test for cervical screening purposes
Abstract
This study shows that the clinical performance and reproducibility of the cobas 4800 HPV test for high-risk human papillomavirus (HPV) detection fulfill the criteria as formulated in international guidelines of HPV test requirements for cervical screening purposes. Accordingly, the cobas 4800 HPV test can be considered clinically validated for cervical screening.
Similar articles
-
Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening.J Clin Microbiol. 2019 Jan 30;57(2):e01239-18. doi: 10.1128/JCM.01239-18. Print 2019 Feb. J Clin Microbiol. 2019. PMID: 30463896 Free PMC article.
-
Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region.J Clin Microbiol. 2014 Mar;52(3):890-6. doi: 10.1128/JCM.03195-13. Epub 2014 Jan 3. J Clin Microbiol. 2014. PMID: 24391196 Free PMC article.
-
Clinical validation of the Abbott RealTime High Risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening.J Clin Microbiol. 2013 Jul;51(7):2409-10. doi: 10.1128/JCM.00633-13. Epub 2013 May 1. J Clin Microbiol. 2013. PMID: 23637297 Free PMC article.
-
Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screening.J Med Virol. 2024 Sep;96(9):e29881. doi: 10.1002/jmv.29881. J Med Virol. 2024. PMID: 39221498 Review.
-
Introduction of human papillomavirus DNA screening in the world: 15 years of experience.Vaccine. 2012 Nov 20;30 Suppl 5:F117-22. doi: 10.1016/j.vaccine.2012.05.071. Vaccine. 2012. PMID: 23199954 Review.
Cited by
-
Laboratory and clinical aspects of human papillomavirus testing.Crit Rev Clin Lab Sci. 2012 Jul-Aug;49(4):117-36. doi: 10.3109/10408363.2012.707174. Crit Rev Clin Lab Sci. 2012. PMID: 22913405 Free PMC article. Review.
-
High-Risk Human Papillomavirus Detection via Cobas® 4800 and REBA HPV-ID® Assays.Viruses. 2022 Dec 3;14(12):2713. doi: 10.3390/v14122713. Viruses. 2022. PMID: 36560717 Free PMC article.
-
Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening.J Clin Microbiol. 2019 Jan 30;57(2):e01239-18. doi: 10.1128/JCM.01239-18. Print 2019 Feb. J Clin Microbiol. 2019. PMID: 30463896 Free PMC article.
-
A novel sequencing-based vaginal health assay combining self-sampling, HPV detection and genotyping, STI detection, and vaginal microbiome analysis.PLoS One. 2019 May 1;14(5):e0215945. doi: 10.1371/journal.pone.0215945. eCollection 2019. PLoS One. 2019. PMID: 31042762 Free PMC article.
-
Predictable changes in the accuracy of human papillomavirus tests after vaccination: review with implications for performance monitoring in cervical screening.Br J Cancer. 2024 May;130(11):1733-1743. doi: 10.1038/s41416-024-02681-z. Epub 2024 Apr 13. Br J Cancer. 2024. PMID: 38615108 Free PMC article. Review.
References
-
- Mateos M. L., de Chacon A. J., Rodriguez-Dominguez M., Sanz I., Rubio M. D. 2011. Evaluation of a prototype real-time PCR assay for the separate detection of human papilloma virus genotypes 16 and 18 and other high risk human papillomavirus in cervical cancer screening. Enferm. Infecc. Microbiol. Clin. 29:411–414 - PubMed
-
- Meijer C. J., Berkhof H., Heideman D. A., Hesselink A. T., Snijders P. J. 2009. Validation of high-risk HPV tests for primary cervical screening. J. Clin. Virol. 46(Suppl. 3):S1–S4 - PubMed
-
- Rijkaart D. C., et al. 2011. Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening. Int. J. Cancer [Epub ahead of print.] doi:10.1002/ijc.26056 - DOI - PubMed